Andreessen Horowitz September 20, 2024
Vineeta Agarwala

Cells are a remarkable unit of life. They carry the ability to reproduce, to grow into tissues and organs, to sense and respond to their environments, to store and use energy, and to manufacture and secrete products of many kinds throughout the body. They have evolved enormous complexity, well beyond our capacity for de novo design. It is not surprising, then, that in many human diseases, when our cells are depleted or aged or not functioning, cellular medicines—delivering new cells back to the body—might offer the most logical and the most comprehensive form of therapeutic intervention available.

Scalable cellular medicines: the holy grail

Cell therapy is indeed a holy grail that has captivated the field of regenerative medicine for decades....

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Investments, Pharma / Biotech, Trends
Answer ALS, Cedars-Sinai Collaboration, Single-Cell Protein Profiling, ChapsVision Acquires Sinequa, More
Pharma Pulse 11/25/24: Deepening Patient Relationships,
Halozyme abandons its €2bn pursuit of Evotec
BridgeBio poised to challenge Pfizer after Attruby approval
Halozyme Pulls €2B Acquisition Bid as Evotec Commits to Standalone Strategy

Share This Article